OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Competing Effects of Renin Angiotensin System Blockade and Sodium-Glucose Cotransporter-2 Inhibitors on Erythropoietin Secretion in Diabetes
Katerina Marathias, Vaia Lambadiari, Konstantinos Markakis, et al.
American Journal of Nephrology (2020) Vol. 51, Iss. 5, pp. 349-356
Open Access | Times Cited: 40
Katerina Marathias, Vaia Lambadiari, Konstantinos Markakis, et al.
American Journal of Nephrology (2020) Vol. 51, Iss. 5, pp. 349-356
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload
Milton Packer, Stefan D. Anker, Javed Butler, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 11, pp. 1381-1392
Open Access | Times Cited: 136
Milton Packer, Stefan D. Anker, Javed Butler, et al.
Journal of the American College of Cardiology (2021) Vol. 77, Iss. 11, pp. 1381-1392
Open Access | Times Cited: 136
Iron Deficiency in Heart Failure and Effect of Dapagliflozin: Findings From DAPA-HF
Kieran F. Docherty, Paul Welsh, Subodh Verma, et al.
Circulation (2022) Vol. 146, Iss. 13, pp. 980-994
Open Access | Times Cited: 100
Kieran F. Docherty, Paul Welsh, Subodh Verma, et al.
Circulation (2022) Vol. 146, Iss. 13, pp. 980-994
Open Access | Times Cited: 100
Hypoxia and chronic kidney disease
Bin Wang, Zuo‐Lin Li, Yilin Zhang, et al.
EBioMedicine (2022) Vol. 77, pp. 103942-103942
Open Access | Times Cited: 84
Bin Wang, Zuo‐Lin Li, Yilin Zhang, et al.
EBioMedicine (2022) Vol. 77, pp. 103942-103942
Open Access | Times Cited: 84
Novel anemia therapies in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Elaine Ku, Lucia Del Vecchio, Kai‐Uwe Eckardt, et al.
Kidney International (2023) Vol. 104, Iss. 4, pp. 655-680
Open Access | Times Cited: 72
Elaine Ku, Lucia Del Vecchio, Kai‐Uwe Eckardt, et al.
Kidney International (2023) Vol. 104, Iss. 4, pp. 655-680
Open Access | Times Cited: 72
Effect of dapagliflozin on anaemia in DAPA‐HF
Kieran F. Docherty, James P. Curtain, Inder S. Anand, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 4, pp. 617-628
Open Access | Times Cited: 74
Kieran F. Docherty, James P. Curtain, Inder S. Anand, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 4, pp. 617-628
Open Access | Times Cited: 74
Angiotensin II up-regulates sodium-glucose co-transporter 2 expression and SGLT2 inhibitor attenuates Ang II-induced hypertensive renal injury in mice
Kana N. Miyata, Chao‐Sheng Lo, Shuiling Zhao, et al.
Clinical Science (2021) Vol. 135, Iss. 7, pp. 943-961
Open Access | Times Cited: 50
Kana N. Miyata, Chao‐Sheng Lo, Shuiling Zhao, et al.
Clinical Science (2021) Vol. 135, Iss. 7, pp. 943-961
Open Access | Times Cited: 50
Beauty and the beast: host microRNA-155 versus SARS-CoV-2
Konstantinos I. Papadopoulos, Alexandra Papadopoulou, Tar Choon Aw
Human Cell (2023) Vol. 36, Iss. 3, pp. 908-922
Open Access | Times Cited: 22
Konstantinos I. Papadopoulos, Alexandra Papadopoulou, Tar Choon Aw
Human Cell (2023) Vol. 36, Iss. 3, pp. 908-922
Open Access | Times Cited: 22
Autophagy Dysregulation in Diabetic Kidney Disease: From Pathophysiology to Pharmacological Interventions
Claudio González, María Paula Carro Negueruela, Catalina Nicora Santamarina, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2497-2497
Open Access | Times Cited: 40
Claudio González, María Paula Carro Negueruela, Catalina Nicora Santamarina, et al.
Cells (2021) Vol. 10, Iss. 9, pp. 2497-2497
Open Access | Times Cited: 40
Effects of SGLT2 inhibitors on haematocrit and haemoglobin levels and the associated cardiorenal benefits in T2DM patients: A meta‐analysis
Qi Tian, Keyu Guo, Jiayi Deng, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 26, Iss. 2, pp. 540-547
Open Access | Times Cited: 28
Qi Tian, Keyu Guo, Jiayi Deng, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 26, Iss. 2, pp. 540-547
Open Access | Times Cited: 28
A Role for SGLT-2 Inhibitors in Treating Non-diabetic Chronic Kidney Disease
Lucia Del Vecchio, Angelo Beretta, Carlo Jovane, et al.
Drugs (2021) Vol. 81, Iss. 13, pp. 1491-1511
Closed Access | Times Cited: 26
Lucia Del Vecchio, Angelo Beretta, Carlo Jovane, et al.
Drugs (2021) Vol. 81, Iss. 13, pp. 1491-1511
Closed Access | Times Cited: 26
Finerenone Efficacy in Patients with Chronic Kidney Disease, Type 2 Diabetes, and Anemia in FIDELITY
A.K. Singh, Glen James, Stefan D. Anker, et al.
JACC Advances (2025) Vol. 4, Iss. 2, pp. 101524-101524
Open Access
A.K. Singh, Glen James, Stefan D. Anker, et al.
JACC Advances (2025) Vol. 4, Iss. 2, pp. 101524-101524
Open Access
MicroRNA-155 modulation by renin-angiotensin system inhibitors may underlie their enigmatic role in COVID-19
Konstantinos I. Papadopoulos, Αλεξάνδρα Παπαδοπούλου, Tar Choon Aw
World Journal of Experimental Medicine (2025) Vol. 15, Iss. 2
Closed Access
Konstantinos I. Papadopoulos, Αλεξάνδρα Παπαδοπούλου, Tar Choon Aw
World Journal of Experimental Medicine (2025) Vol. 15, Iss. 2
Closed Access
From Skepticism to Hope: The Evolving Concept of the Initiation and Use of Sodium-Glucose Cotransporter 2 Inhibitors in Hospitalized Patients
Theocharis Koufakis, Омар Мустафа, Ramzi Ajjan, et al.
Drugs (2022) Vol. 82, Iss. 9, pp. 949-955
Open Access | Times Cited: 16
Theocharis Koufakis, Омар Мустафа, Ramzi Ajjan, et al.
Drugs (2022) Vol. 82, Iss. 9, pp. 949-955
Open Access | Times Cited: 16
The paradigm shift from polycythemia to anemia in COPD: the critical role of the renin–angiotensin system inhibitors
Vassilios Vlahakos, Katerina Marathias, Sophia Lionaki, et al.
Expert Review of Respiratory Medicine (2022), pp. 1-8
Closed Access | Times Cited: 12
Vassilios Vlahakos, Katerina Marathias, Sophia Lionaki, et al.
Expert Review of Respiratory Medicine (2022), pp. 1-8
Closed Access | Times Cited: 12
Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study
Alessandro Maria Berton, Mirko Parasiliti‐Caprino, Nunzia Prencipe, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Alessandro Maria Berton, Mirko Parasiliti‐Caprino, Nunzia Prencipe, et al.
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 7
Treatment Options for Anemia in Kidney Transplant Patients: A Review
Mario Bonomini, Lorenzo Di Liberato, Vittorio Sirolli
Kidney Medicine (2023) Vol. 5, Iss. 8, pp. 100681-100681
Open Access | Times Cited: 7
Mario Bonomini, Lorenzo Di Liberato, Vittorio Sirolli
Kidney Medicine (2023) Vol. 5, Iss. 8, pp. 100681-100681
Open Access | Times Cited: 7
The treatment of chronic anemia in heart failure: a global approach
Vittorio Emanuele Bianchi, Stephan von Haehling
Clinical Research in Cardiology (2023) Vol. 113, Iss. 8, pp. 1117-1136
Closed Access | Times Cited: 7
Vittorio Emanuele Bianchi, Stephan von Haehling
Clinical Research in Cardiology (2023) Vol. 113, Iss. 8, pp. 1117-1136
Closed Access | Times Cited: 7
Combining Iron Supplements With SGLT2 Inhibitor-Stimulated Erythropoiesis in Heart Failure: Should We Be Worried About Thromboembolic Events?
Milton Packer, John G.F. Cleland
Journal of Cardiac Failure (2022) Vol. 29, Iss. 3, pp. 403-406
Open Access | Times Cited: 11
Milton Packer, John G.F. Cleland
Journal of Cardiac Failure (2022) Vol. 29, Iss. 3, pp. 403-406
Open Access | Times Cited: 11
Age and genotype dependent erythropoietin protection in COVID-19
Konstantinos I. Papadopoulos, Warachaya Sutheesophon, Somjate Manipalviratn, et al.
World Journal of Stem Cells (2021) Vol. 13, Iss. 10, pp. 1513-1529
Open Access | Times Cited: 13
Konstantinos I. Papadopoulos, Warachaya Sutheesophon, Somjate Manipalviratn, et al.
World Journal of Stem Cells (2021) Vol. 13, Iss. 10, pp. 1513-1529
Open Access | Times Cited: 13
Hypoxia-Driven Responses in Chronic Kidney Disease
Verónica Miguel, Alba Rojo
Oxygen (2023) Vol. 3, Iss. 3, pp. 300-321
Open Access | Times Cited: 5
Verónica Miguel, Alba Rojo
Oxygen (2023) Vol. 3, Iss. 3, pp. 300-321
Open Access | Times Cited: 5
Cardiovascular benefits of SGLT2 inhibitors in type 2 diabetes, interaction with metformin and role of erythrocytosis: a self-controlled case series study
Carlos King Ho Wong, Kristy T. K. Lau, Eric Ho Man Tang, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Carlos King Ho Wong, Kristy T. K. Lau, Eric Ho Man Tang, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 9
Clinical Implications of the Coexistence of Anemia and Diabetes Mellitus in the Elderly Population
Sylwia Sulimiera Michalak, Edyta Wolny-Rokicka, Elżbieta Nowakowska, et al.
Journal of Diabetes Research (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 11
Sylwia Sulimiera Michalak, Edyta Wolny-Rokicka, Elżbieta Nowakowska, et al.
Journal of Diabetes Research (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 11
The effect of the four pharmacological pillars of heart failure on haemoglobin level
Darshan Hullon, Erfan Taherifard, Taif Haitham AlSaraireh
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 3, pp. 1575-1583
Open Access | Times Cited: 1
Darshan Hullon, Erfan Taherifard, Taif Haitham AlSaraireh
Annals of Medicine and Surgery (2024) Vol. 86, Iss. 3, pp. 1575-1583
Open Access | Times Cited: 1
Anaemia and its risk factors and association with treatments in patients with diabetes: A cross-sectional study
Mathilde Brière, Marc Diedisheim, Léa Dehghani, et al.
Diabetes & Metabolism (2020) Vol. 47, Iss. 1, pp. 101164-101164
Closed Access | Times Cited: 10
Mathilde Brière, Marc Diedisheim, Léa Dehghani, et al.
Diabetes & Metabolism (2020) Vol. 47, Iss. 1, pp. 101164-101164
Closed Access | Times Cited: 10
